PATIENT+ decision aids are being developed with great care. The decision aids are developed using the international IPDAS standards. When developing and implementing our decision aids, we use the ‘'Leidraad keuzehulp bij richtlijnen’' and the most recent scientific literature. We create the content in close collaboration with health care professionals and patients. We approach the corresponding scientific and patient assciations, asking them to be involved during the development as well.
You can read more about the development and implementation of our decision aids here.
Dr. E.M. Baerveldt (dermatologist), dr. M.C.S. Boshuizen (PATIENT+), dr. D. Determann (PATIENT+), I. van Ee (patient representative), drs. W.J.A. de Kort (dermatologist), drs. G.E. van der Kraaij (research doctor), drs. P. Smeets (assistant doctor dermatology), prof. P.I. Spuls (dermatologist), G. Tafuni (patient representative), dr. T. Teunis (PATIENT+).
P.I. Spuls and G.E. van der Kraaij received funding from Stichting Kwaliteitsgelden Medisch Specialisten (Quality Assurance Medical Specialists Foundation) to develop and implement this decision aid. During the past 2 years P.I. Spuls has been on the advisory board of the pharmaceutical company Sanofi once (unpaid). P.I. Spuls and G.E. van der Kraaij also take part in clinical studies researching products from several pharmaceutical companies. W.J.A. de Kort is on the advisory board of the following pharmaceutical companies: Abbvie, Celgene, Janssen, UCB, Novartis and Eli Lilly. W.J.A. de Kort has also taken part in clinical studies researching products from several pharmaceutical companies. The other authors have stated that they have no conflict of interest. The complete ICMJE Conflict of Interest Forms of the authors and employees of PATIENT+ are available on request.